TWI746662B - 眼科用製品及黏度降低抑制方法 - Google Patents

眼科用製品及黏度降低抑制方法 Download PDF

Info

Publication number
TWI746662B
TWI746662B TW106134476A TW106134476A TWI746662B TW I746662 B TWI746662 B TW I746662B TW 106134476 A TW106134476 A TW 106134476A TW 106134476 A TW106134476 A TW 106134476A TW I746662 B TWI746662 B TW I746662B
Authority
TW
Taiwan
Prior art keywords
package
ophthalmic composition
ophthalmic
container
castor oil
Prior art date
Application number
TW106134476A
Other languages
English (en)
Chinese (zh)
Other versions
TW201813669A (zh
Inventor
奥村隆
内藤香菜
石井玲子
Original Assignee
日商獅子股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商獅子股份有限公司 filed Critical 日商獅子股份有限公司
Publication of TW201813669A publication Critical patent/TW201813669A/zh
Application granted granted Critical
Publication of TWI746662B publication Critical patent/TWI746662B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW106134476A 2016-10-07 2017-10-06 眼科用製品及黏度降低抑制方法 TWI746662B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016-199036 2016-10-07
JP2016199036 2016-10-07

Publications (2)

Publication Number Publication Date
TW201813669A TW201813669A (zh) 2018-04-16
TWI746662B true TWI746662B (zh) 2021-11-21

Family

ID=61831491

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106134476A TWI746662B (zh) 2016-10-07 2017-10-06 眼科用製品及黏度降低抑制方法

Country Status (4)

Country Link
JP (2) JP7120018B2 (ja)
KR (1) KR20190065237A (ja)
TW (1) TWI746662B (ja)
WO (1) WO2018066651A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7310113B2 (ja) * 2017-10-04 2023-07-19 ライオン株式会社 眼科用組成物及びその製造方法、ならびに吸着抑制方法
JP2019214560A (ja) * 2018-06-08 2019-12-19 ロート製薬株式会社 洗眼剤組成物
EP3823581A1 (en) 2018-07-18 2021-05-26 ATG 20 S.r.l. Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
CN114533652A (zh) * 2018-09-25 2022-05-27 沈阳兴齐眼科医院有限公司 药物组合物、其制备方法和用途
JP2020196672A (ja) * 2019-05-31 2020-12-10 小林製薬株式会社 ビタミンｂ１２類含有組成物
JP2022099573A (ja) * 2020-12-23 2022-07-05 小林製薬株式会社 洗眼用組成物
WO2024110023A1 (en) * 2022-11-23 2024-05-30 Symrise Ag An active composition comprising retinol

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183778A1 (ja) * 2012-06-08 2013-12-12 ライオン株式会社 粘膜用組成物
CN104127377A (zh) * 2014-08-04 2014-11-05 珠海亿胜生物制药有限公司 一种不含抑菌剂的双氯芬酸钠滴眼液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10193490A (ja) * 1997-01-06 1998-07-28 Mitsubishi Gas Chem Co Inc 水性液状物質の包装方法
JPH1171478A (ja) 1997-08-29 1999-03-16 Santen Pharmaceut Co Ltd 粘度低下防止方法
JP2003113078A (ja) * 2001-09-28 2003-04-18 Lion Corp 眼科用製剤
JP2004123634A (ja) * 2002-10-03 2004-04-22 Lion Corp 眼科用組成物
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
JP5382973B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
JP2006187636A (ja) * 2006-02-01 2006-07-20 Terumo Corp ビタミンｂ１類含有水性製剤の安定化方法
JP2011021002A (ja) * 2009-06-16 2011-02-03 Lion Corp 眼科用組成物
WO2011001951A1 (ja) * 2009-06-30 2011-01-06 ライオン株式会社 眼科用組成物
JP2013237638A (ja) * 2012-05-15 2013-11-28 Lion Corp 眼科組成物
JP6260230B2 (ja) * 2013-11-28 2018-01-17 ライオン株式会社 眼科用組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183778A1 (ja) * 2012-06-08 2013-12-12 ライオン株式会社 粘膜用組成物
CN104127377A (zh) * 2014-08-04 2014-11-05 珠海亿胜生物制药有限公司 一种不含抑菌剂的双氯芬酸钠滴眼液及其制备方法

Also Published As

Publication number Publication date
TW201813669A (zh) 2018-04-16
KR20190065237A (ko) 2019-06-11
WO2018066651A1 (ja) 2018-04-12
JP2022111328A (ja) 2022-07-29
JP7120018B2 (ja) 2022-08-17
JPWO2018066651A1 (ja) 2019-08-08

Similar Documents

Publication Publication Date Title
TWI746662B (zh) 眼科用製品及黏度降低抑制方法
JP7355539B2 (ja) 眼科組成物
KR101858590B1 (ko) 안과용 조성물
JP7314986B2 (ja) 眼科用製品及び粘度低下抑制方法
JP2005154437A (ja) トラニラスト含有医薬組成物
JP2024061871A (ja) 眼科組成物
JP2021178845A (ja) 眼科組成物
JP2023052927A (ja) 水性眼科組成物
JP2022125332A (ja) 眼科組成物
JP2005343894A (ja) 抗菌点眼剤
EP3445331A1 (en) Preservative free pharmaceutical ophthalmic compositions
JP2024010178A (ja) 眼科組成物
JP2023126377A (ja) 眼科組成物
JP2023033557A (ja) 複合目症状改善用眼科組成物
JP2009079032A (ja) 眼科用組成物及びジフェンヒドラミンの安定化方法
JP7380772B2 (ja) 眼科用製品及びマスキング方法
JP2005239691A (ja) トラニラスト含有医薬組成物
JP7379913B2 (ja) ソフトコンタクトレンズ用眼科組成物及び眼科用製品
JP2024059971A (ja) 洗眼剤組成物